Healthcare Innovation April 4, 2024
Pietje Kobus

HHS publishes a white paper on policy considerations to address drug shortages

In an April 2 press release, the U.S. Department of Health and Human Services (HHS) announced the release of a white paper titled Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States. The paper outlines steps HHS has taken to prevent drug shortages. Additionally, the paper highlights solutions for policymakers.

“Hospitals can spend at least $600 million per year managing shortages,” the white paper reads. Shortages of life-saving drugs are a concern for patient care, health, and safety. According to HHS, there has been a shortage of 123 drugs as of January.

A new coordinator role has been established to help HHS...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, HHS, Pharma, Pharma / Biotech
Familiar face in the tech policy office
HHS Secretary RFK Jr. Urges Parents to Consider Measles Shot
What HHS' public comment rollback means for hospitals: 3 federal health updates
RFK Jr. move to kill public comment roils providers
New HHS Rule Wipes Out Some Public Comment on Rulemaking

Share This Article